Therapeutic Plasma Exchange, Rituximab and IV Ig for Severe Acute Exacerbation of IPF Admitted in ICU

NCT03584802 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Exacerbation of Idiopathic Pulmonary Fibrosis

Interventions

OTHER: Therapeutic plasma exchanges
OTHER: Conventional treatment of AE-IPF

Sponsor

Assistance Publique - Hôpitaux de Paris